The diagnosis, prevention and treatment on COVID-19 from April 9th is now featured in Radiology’s special edition of their most highly cited and most influential articles published during the pandemic on COVID-19 imaging related topics.
The publication Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands was one of the premier documents highlighting the presence and consequences of local thrombosis in the lungs of COVID-19 patients. Since then, the thrombotic processes in COVID-19 patients have been recognised internationally as one of the leading causes of mortality.
iDNA continues to focus on supporting COVID-19 related research. In cooperation with academic partners, we are currently investigating the preventive effects of anticoagulant therapies in COVID-19. By retrospectively studying populations who were already using anticoagulants for other indications when they were diagnosed with COVID-19, we can assess whether these patients were protected from developing more severe symptoms.
With vaccines for COVID-19 under way, we are confronted with limitations in the availability and distribution of vaccines worldwide. Research into anticoagulants will hopefully help to find additional solutions to relieve the impact of COVID-19 on hospital wards and ICU’s.
